cinnarizine and Arterial-Occlusive-Diseases

cinnarizine has been researched along with Arterial-Occlusive-Diseases* in 9 studies

Reviews

1 review(s) available for cinnarizine and Arterial-Occlusive-Diseases

Article	Year
Mechanisms of vasodilatation and antivasoconstriction. Angiology, 1979, Volume: 30, Issue:7 Topics: Actins; Adrenergic alpha-Antagonists; Angiotensin II; Arterial Occlusive Diseases; Bradykinin; Calcium; Cinnarizine; Dose-Response Relationship, Drug; Humans; Muscle, Smooth; Myosins; p-Methoxy-N-methylphenethylamine; Papaverine; Piperazines; Prostaglandins; Theophylline; Vasoconstriction; Vasodilation	1979

Article

Year

Mechanisms of vasodilatation and antivasoconstriction.

Angiology, 1979, Volume: 30, Issue:7

Topics: Actins; Adrenergic alpha-Antagonists; Angiotensin II; Arterial Occlusive Diseases; Bradykinin; Calcium; Cinnarizine; Dose-Response Relationship, Drug; Humans; Muscle, Smooth; Myosins; p-Methoxy-N-methylphenethylamine; Papaverine; Piperazines; Prostaglandins; Theophylline; Vasoconstriction; Vasodilation

1979

Trials

2 trial(s) available for cinnarizine and Arterial-Occlusive-Diseases

Article	Year
[Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy]. Deutsche medizinische Wochenschrift (1946), 1985, Aug-02, Volume: 110, Issue:31-32 Topics: Arterial Occlusive Diseases; Cardiovascular Agents; Cinnarizine; Clinical Trials as Topic; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Exercise Test; Flunarizine; Humans; Intermittent Claudication; Nafronyl; Pentoxifylline; Placebos; Pyrrolidines; Secologanin Tryptamine Alkaloids; Yohimbine	1985
[Therapeutic use of flunarizine in the treatment arteriopathies of the lower extremities]. Minerva medica, 1983, Mar-31, Volume: 74, Issue:13 94 patients with Stage II obliterating arteriopathy of the lower extremities, treated with Flunarizine (10-20 mg per diem), were checked every two months for a 6 month period. Of the 76 patients reaching the final check up, 58 had received no previous treatment and 18 had ischemias secondary to reconstructive vascular surgery. Clinical improvement in terms of increased independent mobility and improved Doppler flowmeter pressure readings were noted in both groups. In view of its beneficial effects on blood vessel function in other areas, Flunarizine is felt to be a valuable drug for the treatment of peripheral arteriopathies, both initially and in cases of ischaemia following vascular surgery. Topics: Aged; Arterial Occlusive Diseases; Chronic Disease; Cinnarizine; Clinical Trials as Topic; Female; Flunarizine; Humans; Ischemia; Leg; Male; Middle Aged; Piperazines; Regional Blood Flow; Rheology; Time Factors; Ultrasonography; Vasodilator Agents	1983

Article

Year

[Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy].

Deutsche medizinische Wochenschrift (1946), 1985, Aug-02, Volume: 110, Issue:31-32

Topics: Arterial Occlusive Diseases; Cardiovascular Agents; Cinnarizine; Clinical Trials as Topic; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Exercise Test; Flunarizine; Humans; Intermittent Claudication; Nafronyl; Pentoxifylline; Placebos; Pyrrolidines; Secologanin Tryptamine Alkaloids; Yohimbine

1985

[Therapeutic use of flunarizine in the treatment arteriopathies of the lower extremities].

Minerva medica, 1983, Mar-31, Volume: 74, Issue:13

94 patients with Stage II obliterating arteriopathy of the lower extremities, treated with Flunarizine (10-20 mg per diem), were checked every two months for a 6 month period. Of the 76 patients reaching the final check up, 58 had received no previous treatment and 18 had ischemias secondary to reconstructive vascular surgery. Clinical improvement in terms of increased independent mobility and improved Doppler flowmeter pressure readings were noted in both groups. In view of its beneficial effects on blood vessel function in other areas, Flunarizine is felt to be a valuable drug for the treatment of peripheral arteriopathies, both initially and in cases of ischaemia following vascular surgery.

Topics: Aged; Arterial Occlusive Diseases; Chronic Disease; Cinnarizine; Clinical Trials as Topic; Female; Flunarizine; Humans; Ischemia; Leg; Male; Middle Aged; Piperazines; Regional Blood Flow; Rheology; Time Factors; Ultrasonography; Vasodilator Agents

1983

Other Studies

6 other study(ies) available for cinnarizine and Arterial-Occlusive-Diseases

Article	Year
[Rheologic therapy of peripheral arteriopathies. Personal observations on the use of flunarizin]. La Clinica terapeutica, 1984, Aug-15, Volume: 110, Issue:3 Topics: Aged; Arterial Occlusive Diseases; Blood Circulation; Calcium Channel Blockers; Cinnarizine; Female; Flunarizine; Humans; Leg; Male; Middle Aged; Piperazines; Rheology; Vasodilator Agents	1984
[The therapeutic effects of flunarizine in peripheral arterial diseases and cerebrovascular diseases]. La Clinica terapeutica, 1982, Dec-15, Volume: 103, Issue:5 Topics: Adult; Aged; Arterial Occlusive Diseases; Cerebrovascular Disorders; Cinnarizine; Female; Flunarizine; Humans; Male; Middle Aged; Piperazines; Raynaud Disease; Vasodilator Agents	1982
Non-surgical management of peripheral vascular disease. British medical journal, 1980, Nov-08, Volume: 281, Issue:6250 Topics: Arterial Occlusive Diseases; Cinnarizine; Cyclandelate; Dilatation; Humans; Intermittent Claudication	1980
Action of cinnarizine on the hyperviscosity of blood in patients with peripheral obliterative arterial disease. Angiology, 1979, Volume: 30, Issue:1 Cinnarizine, a drug capable of improving blood flow, was studied for its action on blood viscosity and its main components in patients affected by peripheral obliterative arterial diseases (POAD). Both acute and chronic administration of the drug diminished the increased whole-blood viscosity in patients, without affecting plasma and serum viscosity, hematocrit, plasma fibrinogen concentration, and plasma osmolality. Since cinnarizine also led to a significant increase of peripheral muscular blood flow, it was hypothesized that this action may be due to an increased deformability of the red cells, and may play a considerable role in the therapeutic approach to POAD. Topics: Arterial Occlusive Diseases; Blood Viscosity; Cinnarizine; Female; Humans; Male; Middle Aged; Piperazines	1979
Specific calcium antagonists in the treatment of peripheral vascular disease. Angiology, 1979, Volume: 30, Issue:7 Topics: Arterial Occlusive Diseases; Arteriosclerosis; Biological Transport; Blood Viscosity; Calcium; Cell Membrane Permeability; Cinnarizine; Humans; Intermittent Claudication; Muscle, Smooth; Papaverine; Vascular Diseases	1979
Action of cinnarizine on the blood flow of the lower limbs in patients affected by obliterative peripheral arterial disease and in normal subjects. VASA. Zeitschrift fur Gefasskrankheiten, 1976, Volume: 5, Issue:4 Topics: Adult; Aged; Arterial Occlusive Diseases; Cinnarizine; Female; Humans; Leg; Male; Middle Aged; Piperazines; Regional Blood Flow; Rest	1976